Your browser doesn't support javascript.
loading
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies.
Kerbauy, Lucila N; Marin, Nancy D; Kaplan, Mecit; Banerjee, Pinaki P; Berrien-Elliott, Melissa M; Becker-Hapak, Michelle; Basar, Rafet; Foster, Mark; Garcia Melo, Luciana; Neal, Carly C; McClain, Ethan; Daher, May; Nunez Cortes, Ana Karen; Desai, Sweta; Inng Lim, Francesca Wei; Mendt, Mayela Carolina; Schappe, Timothy; Li, Li; Shaim, Hila; Shanley, Mayra; Ensley, Emily L; Uprety, Nadima; Wong, Pamela; Liu, Enli; Ang, Sonny O; Cai, Rong; Nandivada, Vandana; Mohanty, Vakul; Miao, Qi; Shen, Yifei; Baran, Natalia; Fowlkes, Natalie W; Chen, Ken; Muniz-Feliciano, Luis; Champlin, Richard E; Nieto, Yago L; Koch, Joachim; Treder, Martin; Fischer, Wolfgang; Okamoto, Oswaldo Keith; Shpall, Elizabeth J; Fehniger, Todd A; Rezvani, Katayoun.
  • Kerbauy LN; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marin ND; Departments of Stem Cell Transplantation and Hemotherapy/Cellular Therapy, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Kaplan M; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), Sao Paulo, Brazil.
  • Banerjee PP; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Berrien-Elliott MM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Becker-Hapak M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Basar R; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Foster M; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Garcia Melo L; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Neal CC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • McClain E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daher M; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Nunez Cortes AK; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Desai S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Inng Lim FW; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mendt MC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Schappe T; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li L; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shaim H; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Shanley M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ensley EL; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Uprety N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wong P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ang SO; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Cai R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nandivada V; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mohanty V; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Miao Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shen Y; Department of Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Baran N; Department of Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Fowlkes NW; Department of Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Chen K; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Muniz-Feliciano L; Department of Veterinary Medicine and Surgery, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Champlin RE; Department of Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Nieto YL; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Koch J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Treder M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fischer W; Affimed GmbH, Heidelberg, Germany.
  • Okamoto OK; Arjuna Therapeutics, Santiago de Compostela, Spain.
  • Shpall EJ; Affimed GmbH, Heidelberg, Germany.
  • Fehniger TA; Departments of Stem Cell Transplantation and Hemotherapy/Cellular Therapy, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Rezvani K; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), Sao Paulo, Brazil.
Clin Cancer Res ; 27(13): 3744-3756, 2021 07 01.
Article en En | MEDLINE | ID: mdl-33986022
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Leucemia / Anticuerpos Biespecíficos / Inmunoterapia / Linfoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Leucemia / Anticuerpos Biespecíficos / Inmunoterapia / Linfoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article